Keywords: |
adult; cancer survival; treatment outcome; middle aged; retrospective studies; overall survival; prednisone; clinical feature; case report; salvage therapy; cisplatin; doxorubicin; interferon; cytarabine; drug megadose; cd34 antigen; carboplatin; progression free survival; multiple cycle treatment; etoposide; recurrence; calcium; cyclophosphamide; melphalan; vincristine; autologous stem cell transplantation; calcium blood level; hypercalcemia; hematopoietic stem cell transplantation; carmustine; ifosfamide; thiotepa; new york city; lactate dehydrogenase; methylprednisolone; leukemia relapse; t cell leukemia; transplantation, autologous; lactate dehydrogenase blood level; lymphadenopathy; north america; bone marrow disease; zidovudine; human t cell leukemia virus 1; leukemia remission; nk t cell lymphoma; caribbean region; htlv-i infections; human t-lymphotropic virus 1; latin america; leukemia-lymphoma, adult t-cell
|